Names, Routes, and Classes Flashcards

1
Q

Dasatinib

A

[SPRYCEL]
P.O.
TKI for BCR-ABL1 (Ph+) CML, sometimes Acute Leukemias (that are also Ph+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Denosumab

A

[PROLIA, XGEVA]
S.Q.
mAb (RANK ligand inhibitor)
Prevents bone loss/hyperCa++ for bone lesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bortezomib

A

[VELCADE]
I.V. or S.Q.
Proteasome Inhibitor
1st+ for MM, 2nd+ for MCL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ibrutinib

A

[IMBRUVICA]
P.O.
BTK inhibitor
CLL/SLL, esp. with del(17p); WM; 2nd line MZL; cGVHD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Zanubrutinib

A

[BRUKINSA]
P.O.
BTK inhibitor
2nd line MCL and MZL; WM; CLL/SLL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly